|1.||Zanelli, S A: 1 article (01/2005)|
|2.||Mishra, O P: 1 article (01/2005)|
|3.||Spandou, E: 1 article (01/2005)|
|4.||Delivoria-Papadopoulos, M: 1 article (01/2005)|
|5.||Erneux, C: 1 article (10/2001)|
|6.||Vandekerckhove, J: 1 article (10/2001)|
|7.||Communi, D: 1 article (10/2001)|
|8.||Demol, H: 1 article (10/2001)|
|9.||Gevaert, K: 1 article (10/2001)|
10/01/1993 - "Inositol-1,3,4,5-tetrakisphosphate induces calcium mobilization via the inositol-1,4,5-trisphosphate receptor in SH-SY5Y neuroblastoma cells."
08/15/1993 - "Ins(1,3,4,5)P4 was able to mobilize the entire Ins(1,4,5)P3-sensitive intracellular Ca2+ store in saponin-permeabilized SH-SY5Y human neuroblastoma cells in a concentration-dependent manner, yielding an EC50 value of 2.05 +/- 0.45 microM, compared with 0.14 +/- 0.03 microM for Ins(1,4,5)P3. "
02/01/1991 - "Accumulation and metabolism of Ins(1,4,5)P3 and Ins(1,3,4,5)P4 in muscarinic-receptor-stimulated SH-SY5Y neuroblastoma cells."
12/27/1993 - "Myo-inositol 1,3,4,5-tetrakisphosphate [Ins(1,3,4,5)P4] acts as a full agonist for Ca2+ release in saponin-permeabilised SH-SY5Y neuroblastoma cells. "
11/24/1986 - "Iontophoretic injections of inositol 1,4,5-trisphosphate inside neuroblastoma X glioma NG108-15 hybrid cells evoked an outward K+ current across the outer cell membrane, probably activated by the release of intracellular Ca2+. No such current was produced by equivalent intracellular injections of inositol 1,3,4-trisphosphate or inositol 1,3,4,5-tetrakisphosphate. "
10/15/1990 - "Synergistic control of Ca2+ mobilization in permeabilized mouse L1210 lymphoma cells by inositol 2,4,5-trisphosphate and inositol 1,3,4,5-tetrakisphosphate."
05/01/1989 - "Inositol 1,3,4,5-tetrakisphosphate causes release of Ca2+ from permeabilized mouse lymphoma L1210 cells by its conversion into inositol 1,4,5-trisphosphate."
10/15/1990 - "L1210 lymphoma cells were permeabilized with digitonin, and the ability of Ins(2,4,5)P3 and Ins(1,3,4,5)P4 to mobilize intracellular Ca2+ was studied. "
|3.||Acute Erythroblastic Leukemia (Erythroleukemia)
01/01/1999 - "Antisense knock out of the inositol 1,3,4,5-tetrakisphosphate receptor GAP1(IP4BP) in the human erythroleukemia cell line leads to the appearance of intermediate conductance K(Ca) channels that hyperpolarize the membrane and enhance calcium influx."
08/05/1990 - "Human erythroleukemia (HEL) cells phosphorylate [3H]inositol 1,4,5-trisphosphate to inositol 1,3,4,5-tetrakisphosphate; they also contain all the enzymes to sequentially dephosphorylate [3H]inositol 1,4,5-trisphosphate and [3H]inositol 1,3,4,5-tetrakisphosphate to inositol. "
|4.||Astrocytoma (Pilocytic Astrocytoma)
08/01/1988 - "Compounds with chromatographic and chemical properties consistent with the structures myo-inositol 1,3,4,5-tetrakisphosphate, myo-inositol 1,3,4,6-tetrakisphosphate and myo-inositol 3,4,5,6-tetrakisphosphate are present in avian erythrocytes, human 1321 N1 astrocytoma cells and primary-cultured murine bone-marrow-derived macrophages. "
10/19/2001 - "Transient and okadaic acid-sensitive inhibition by 70-85% of Ins(1,4,5)P(3) and Ins(1,3,4,5)P(4) 5-phosphatase activities was observed in homogenates from rat cortical astrocytes, human astrocytoma 1321N1 cells, and rat basophilic leukemia RBL-2H3 cells after incubation with carbachol. "
|5.||Optic Nerve Injuries
|7.||Muscarinic Receptors (Muscarinic Acetylcholine Receptor)